BlackRock Health Sciences Trust II (NYSE:BMEZ) Shares Sold by Moors & Cabot Inc.

Moors & Cabot Inc. trimmed its position in shares of BlackRock Health Sciences Trust II (NYSE:BMEZ – Get Rating) by 8.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,784 shares of the company’s stock after selling 867 shares during the quarter. Moors & Cabot Inc.’s holdings in BlackRock Health Sciences Trust II were worth $248,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Hollencrest Capital Management acquired a new position in shares of BlackRock Health Sciences Trust II during the fourth quarter worth about $30,000. MUFG Americas Holdings Corp acquired a new position in BlackRock Health Sciences Trust II during the third quarter worth about $30,000. Arlington Partners LLC acquired a new position in BlackRock Health Sciences Trust II during the fourth quarter worth about $46,000. Northern Trust Corp acquired a new position in BlackRock Health Sciences Trust II during the second quarter worth about $205,000. Finally, B. Riley Wealth Advisors Inc. acquired a new position in BlackRock Health Sciences Trust II during the third quarter worth about $209,000.

BlackRock Health Sciences Trust II Stock Performance

Shares of BMEZ opened at 16.19 on Monday. The firm’s 50-day moving average is 16.19 and its two-hundred day moving average is 16.05. BlackRock Health Sciences Trust II has a twelve month low of 14.33 and a twelve month high of 17.89.

BlackRock Health Sciences Trust II Announces Dividend

The business also recently announced a monthly dividend, which will be paid on Wednesday, May 31st. Shareholders of record on Monday, May 15th will be given a dividend of $0.145 per share. The ex-dividend date of this dividend is Friday, May 12th. This represents a $1.74 annualized dividend and a yield of 10.75%.

BlackRock Health Sciences Trust II Company Profile

(Get Rating)

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.